跳至主要内容
临床试验/DRKS00000702
DRKS00000702已完成不适用

Prospective multi-center study of health risks after acute ingestion of cleaning and cosmetic products containing surfactant

Vergiftungs-Informations-ZentraleZentrum für Kinder- und JugendmedizinUniversitätsklinikum Freiburg0 个研究点目标入组 605 人开始时间: 2011年7月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
605

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • Confirmed oral exposure of manual dishwashing detergents, soaps, shampoos, bathing supplements, general purpose cleaners or laundry detergents. The approval of study participation.

排除标准

  • Not confirmed ingestion, multi-ingestion

研究者

发起方
Vergiftungs-Informations-ZentraleZentrum für Kinder- und JugendmedizinUniversitätsklinikum Freiburg

相似试验

进行中(未招募)
不适用
Retrospective multicenter clinical study of risk factors for cetuximab-related infusion reaction in Japanese patientsColorectal Cancer, Head and Neck Cancer
JPRN-jRCT1040210116Onoda Chiharu244
招募中
不适用
Multicenter prospective study of risk factors for conversion to laparotomy in patients undergoing laparoscopic liver resection. (HiSCO 08)iver tumor
JPRN-UMIN000039957Gasroenterological Surgery, Hiroshima University Hospital200
招募中
不适用
A multi-center prospective study on incidence of adenocarcinoma in Japanese patients with Barrett's esophagusBarrett&#39s esophagus
JPRN-UMIN000003789Division of Gastroenterology, Tohoku University Hospital100
招募中
不适用
Prospective multicenter study regarding the safety of surgical results of laparoscopic pancreatic resection; Japanese Society for Endoscopic Pancreatic Surgery, Japanese Society of Hepato-Biliary-Pancreatic Surgery, and Japan Society for Endoscopic Surgery cooperative studyPancreatobiliary diseases (Patients planned to undergo laparoscopic pancreatic resection)
JPRN-UMIN000022836Japanese Society for Endoscopic Pancreatic Surgery3,000
已完成
不适用
A multicenter prospective study of risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in cancer patients receiving intravenous bisphosphonate or denosumab therapyCancer patients receiving high-dose bone-modifying agents who tooth extraction were performed
JPRN-UMIN000033743Kobe University Graduate School of Medicine30